Comparison of Dexmedetomidine and Midazolam for Intra-op Sedation in TIVA in Children Undergoing Inguinal Hernia Repair
- Registration Number
- NCT05337085
- Lead Sponsor
- Sheikh Zayed Medical College
- Brief Summary
To compare dexmedetomidine and midazolam for intra-op sedation in TIVA in children undergoing inguinal hernia repair. The results of the study if found significant will guide the anesthetist in appropriate choice and dose of sedative drug with highest efficacy and minimum side effects to avoid post operative adverse effects associated with anesthesia
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 185
Inclusion Criteria
- Male and female paediatric patients In age range neonates to 15 years
- Planned for elective inguinal hernia repair
- Patients with uncomplicated hernia With ASA class I or II
Exclusion Criteria
- Patients undergoing emergency inguinal repair
- Patients with ASA class III,IV,V or VI
- Patients present with complicated hernia
- Patients with BMI above 40kg/m2
- Patients with any allergy to anesthesia
- Patients with coagulopathy
- Patients with narcotic/opioid addiction
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Dexmedetomidine Dexmedetomidine Inj. Dexmedetomidine (precidex) 200/mcg/2ml given to participants in infusion form for 10 mins of surgery and maintenance dose given till the end of surgery Midazolam Midazolam Inj midazolam 0.5 mg/kg stat dose will be given to participants during surgery
- Primary Outcome Measures
Name Time Method Level of sedation assessed through Ramsay Sedation Scale RSS 6 months
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of dexmedetomidine and midazolam in pediatric intraoperative sedation under TIVA?
How does dexmedetomidine compare to midazolam as a standard-of-care sedative in pediatric inguinal hernia surgery under TIVA?
Are there specific biomarkers predicting response to dexmedetomidine versus midazolam in pediatric TIVA for inguinal hernia repair?
What are the safety profiles and adverse event management strategies for dexmedetomidine and midazolam in pediatric TIVA for inguinal hernia repair?
What alternative sedative agents or combination therapies are studied for pediatric TIVA in inguinal hernia repair besides dexmedetomidine and midazolam?